Insights On Trial Design
-
Phase 1 Clinical Trial Designs Explained: BOIN, CRM, BLRM, And Modern Adaptive Strategies
9/25/2025
As precision medicine evolves, trial designs must increasingly accommodate personalized therapies, adaptive strategies, and AI-driven modeling.
-
The Phase 2 Endpoint Dilemma
3/31/2026
Phase 2 neuro endpoints can miss subtle change. Learn when composites help or hinder, how to align cognition, function, and biomarkers with real-world data for go/no-go decisions.
-
Supporting Participants Through National Travel Disruptions
12/10/2025
A sudden travel shutdown threatened a critical clinical visit. Rapid rescheduling, coordinated logistics, and clear communication ensured engagement and the ability to continue without interruption.
-
Mastering Precision Oncology Start-Up: Reducing Screening Delays
3/30/2026
Biomarker-driven trials create intricate screening hurdles. Explore creative, practical ways to accelerate start‑up, boost enrollment, and power precision oncology studies forward with greater speed.
-
Avoiding The Gotchas: RTSM Build Tips From A Seasoned PM
3/25/2026
Small protocol details can create outsized challenges when definitions are unclear or when integrations aren’t planned early.
-
Powering Complex Personalized Medicine Oncology Trial
2/25/2026
Managing custom therapies requires a synchronized supply chain. Learn how to bridge the gap between manufacturing and clinical workflows to ensure seamless patient care in complex oncology trials.
-
Understanding The New FDA Guidance On Decentralized Clinical Trials
2/11/2025
Explore the evolution of the FDA decentralized clinical trial (DCT) guidance, highlighting key updates on responsibilities, data variability, inspections, and trial design.
-
Linking Neurology And Ophthalmology For Clinical Trials
1/22/2025
Learn more about the innovative approach being taken to incorporate ophthalmology into neurology and central nervous system (CNS) research.
-
Control And Transparency: Solving Sponsors' Key Challenges In Study Launch
9/10/2024
Learn how SaaS technology can revolutionize clinical trial launches by improving transparency, increasing control, and streamlining efficiency.
-
How In-Home Trials Can Shift The Pediatric Rare Disease Research Landscape
1/6/2026
DCT solutions are not just about bringing the trial to the patient’s home and reducing logistical burdens, but also strengthening the family-researcher connection.